En Es
Categories

Industry News

UK to Set Up New GBP 10 Million Centre for Medical Imaging and AI

By Medimaging International staff writers
23 Nov 2018

Image: The new centre is intended to help clinicians speed up and improve diagnosis and care across a number of patient pathways, including dementia, heart failure and cancer (Photo courtesy of Imperial College London).The UK’s London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare will train sophisticated artificial intelligence (AI) algorithms from NHS medical images and patient data, to create tools that will help clinicians speed up and improve diagnosis and care across a number of patient pathways, including dementia, heart failure and cancer.

Awarded by UK Research and Innovation as part of the Industrial Strategy Challenge Fund, the centre is led by King's College London and brings together experts from Imperial College London (UK), Queen Mary’s University London (UK) and various healthcare partners.

The centre will focus on transformation and value-based healthcare, and how advanced imaging and AI technologies can be used to improve the patient journey - from earlier diagnosis if there is a problem and reassurance if not, to moving quickly to a treatment which is tailored to the patient and will result in the best possible outcome. By optimizing triage and targeting resources, these technologies will also allow the NHS to reduce wasted effort that is not supporting patient care, and deliver significant financial savings.

"AI has tremendous potential in radiology and medical imaging. The centre will take the lead in translating cutting edge AI research from the lab into the clinic while addressing challenges such as the verification of AI systems and ensuring their interpretability, which is vital for enabling safe deployment in the NHS," said Professor Daniel Rueckert, Head of Imperial's Department of Computing.

"The centre will provide a fantastic opportunity to transform 12 different patient pathways by using advanced imaging and AI and help make the products that will substantially improve the experience for our patients and their clinical outcomes. It will also allow us to better utilize the resources within the NHS," said Centre Director Professor Reza Razavi from King’s College London. "This builds on a great on-going partnership between our researchers, clinicians and industry colleagues that will help put the UK at the forefront of developing and applying new technologies to improve healthcare."

"Early diagnosis of illness can greatly increase the chances of successful treatment and save lives," said UK Research and Innovation Chief Executive Professor Sir Mark Walport. "The centers announced today bring together the teams that will develop artificial intelligence tools that can analyze medical images varying from X-rays to microscopic sections from tissue biopsies. AI has the potential to revolutionize the speed and accuracy of medical diagnosis."

Related Links:
Imperial College London
Queen Mary’s University London



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

23 Nov 2018
AI Predicts Alzheimer’s Disease Years before Diagnosis
A new study on the application of deep learning (DL) to detect changes in brain metabolism predictive of Alzheimer’s disease (AD) has found that artificial intelligence (AI) improves the ability of brain imaging to predict AD.
Read More
23 Nov 2018
New AI Algorithm Enhances Polyp Detection in Colonoscopy Procedures
Researchers at Shanghai Wision AI Co., Ltd., a developer of computer-aided diagnostic algorithms and systems to improve the accuracy and effectiveness of diagnostic imaging, have announced results of a study validating a novel machine-learning algorithm that improves detection of adenomatous polyps during colonoscopy. The AI algorithm is built on the same network architecture that is used to develop self-driving cars and is designed to enable “self-driving” in colonoscopy procedures.
Read More
20 Nov 2018
Study Finds AI Falls Short When Analyzing Medical Data
A study conducted at the Icahn School of Medicine at Mount Sinai has found that artificial intelligence (AI) tools trained to detect pneumonia on chest X-rays suffered significant decreases in performance when tested on data from outside health systems. These findings suggest that unless AI in the medical space is carefully tested for performance across a wide range of populations, the deep learning models may not perform as accurately as expected.
Read More
20 Nov 2018
New AI Software for Brain Bleed Diagnosis Receives FDA Clearance
The US Food and Drug Administration (FDA) has given 510(k) clearance to the Accipio Ix intracranial hemorrhage (ICH) detection software developed by MaxQ AI, a clinical diagnostics intelligence platform company.
Read More
20 Nov 2018
Global Refurbished Medical Devices Market to Increase by 10% by 2023
The global refurbished medical devices market is expected to grow at a CAGR of over 10% during the forecast period 2019-2023, driven by the organized healthcare ecosystem in the developed economies. Moreover, privatization in the healthcare sector is increasing rapidly due to the inability of governments to invest efficiently in the sector, coupled with high demand for innovation and technology for superior healthcare services.
Read More
12 Nov 2018
ACR Data Science Institute Releases AI Use Cases to Accelerate AI Adoption
The American College of Radiology Data Science Institute has released a first-of-its-kind series of standardized artificial intelligence (AI) use cases that will accelerate medical imaging AI adoption. This continually updated, freely available use case series is the product of a previously missing and collaborative framework that enables efficient creation, implementation and ongoing improvement of radiological AI tools.
Read More
12 Nov 2018
Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics
Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country.
Read More
12 Nov 2018
OpenSight Augmented Reality System for Microsoft HoloLens Cleared by FDA
The FDA has granted 510(k) clearance to the OpenSight Augmented Reality System, making it the first AR medical solution for Microsoft HoloLens to be cleared for use in pre-operative surgical planning. Developed by Novarad, a provider of specialized enterprise imaging and workflow solutions, OpenSight renders 2D, 3D and 4D images of patients interactively, while accurately overlaying them directly onto the patient’s body.
Read More
12 Nov 2018
New AR Device Helps Cardiologists Plan and Perform Complex Procedures
Augmented Reality (AR), a technology that superimposes computer-generated information on a user's view of the real world, offers a new platform to help physicians better visualize complex medical data, particularly before and during medical procedures.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions